sb 216763 has been researched along with Lung Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Khuri, FR; Koo, J; Owonikoko, TK; Ramalingam, SS; Sun, SY; Wang, X | 1 |
Chen, WS; Li, JS; Tian, D; Wang, X; Wu, RL; Zhu, M | 1 |
2 other study(ies) available for sb 216763 and Lung Neoplasms
Article | Year |
---|---|
GSK3 is required for rapalogs to induce degradation of some oncogenic proteins and to suppress cancer cell growth.
Topics: Adaptor Proteins, Signal Transducing; Animals; Antibiotics, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Carrier Proteins; Cell Cycle; Cell Line, Tumor; Drug Interactions; Enzyme Activation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Lung Neoplasms; Maleimides; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Mice; Mice, Nude; Multiprotein Complexes; Neoplasm Proteins; Proteasome Endopeptidase Complex; Protein Stability; Proteolysis; Pyridines; Pyrimidines; Rapamycin-Insensitive Companion of mTOR Protein; Recombinant Fusion Proteins; Regulatory-Associated Protein of mTOR; RNA Interference; RNA, Small Interfering; Sirolimus; TOR Serine-Threonine Kinases; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays | 2015 |
Role of glycogen synthase kinase 3 in squamous differentiation induced by cigarette smoke in porcine tracheobronchial epithelial cells.
Topics: Animals; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Enzyme Inhibitors; Gene Expression; Glycogen Synthase Kinase 3; Indoles; Lithium; Lung Neoplasms; Maleimides; Metaplasia; Precancerous Conditions; Protein Precursors; Respiratory Mucosa; Signal Transduction; Smoke; Swine; Transcription Factor AP-1 | 2006 |